Abstract:Short-chain fatty acids (SCFAs), especially butyrate, produced in mammalian intestinal tracts via fermentation of dietary fiber, are known biofunctional compounds in humans. However, the variability of fermentable fiber consumed on a daily basis and the diversity of gut microbiota within individuals often limits the production of short-chain fatty acids in the human gut. In this study, we attempted to enhance the butyrate levels in human fecal samples by utilizing butyl-fructooligosaccharides (B-FOS) as a novel prebiotic substance. Two major types of B-FOS (GF3-1B and GF3-2B), composed of short-chain fructooligosaccharides (FOS) bound to one or two butyric groups by ester bonds, were synthesized. Qualitative analysis of these B-FOS using Fourier transform infrared (FT-IR) spectroscopy, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), nuclear magnetic resonance (NMR) and low-resolution fast-atom bombardment mass spectra (LR-FAB-MS), showed that the chemical structure of GF3-1B and GF3-2B were [O-(1-buty-β-D-fru-(2→1)-O-β-D-fru-(2→1)-O-β-D-fru-O-α-D-glu] and [O-(1-buty)-β-D-fru-(2→1)-O-β-D-fru-(2→1)-O-(4-buty)-β-D-fru-O-α-D-glu], respectively. The ratio of these two compounds was approximately 5:3. To verify their biofunctionality as prebiotic oligosaccharides, proliferation and survival patterns of human fecal microbiota were examined in vitro via 16S rRNA metagenomics analysis compared to a positive FOS control and a negative control without a carbon source. B-FOS treatment showed different enrichment patterns on the fecal microbiota community during fermentation, and especially stimulated the growth of major butyrate producing bacterial consortia and modulated specific butyrate producing pathways with significantly enhanced butyrate levels. Furthermore, the relative abundance of Fusobacterium and ammonia production with related metabolic genes were greatly reduced with B-FOS and FOS treatment compared to the control group. These findings indicate that B-FOS differentially promotes butyrate production through the enhancement of butyrate-producing bacteria and their metabolic genes, and can be applied as a novel prebiotic compound in vivo.

In Vitro Assessment of Prebiotic Properties of Oligosaccharides Derived from Four Microbial Polysaccharides

Study on Prebiotic Effects of Some Oligosaccharides in Vitro

In Vitro Digestibility and Prebiotic Potential of Curdlan (1 → 3)-Β-d-glucan Oligosaccharides in Lactobacillus Species.

Influence of oligosaccharides on the growth and tolerance capacity of lactobacilli to simulated stress environment.

Prebiotic Oligosaccharides Change the Concentrations of Short-Chain Fatty Acids and the Microbial Population of Mouse Bowel.

Dietary Galactosyl and Mannosyl Carbohydrates: In-vitro Assessment of Prebiotic Effects.

Metabolic Profiles of Oligosaccharides Derived from Four Microbial Polysaccharides by Faecal Inocula from Type 2 Diabetes Patients

Prebiotic Dietary Fiber and Gut Health: Comparing the in Vitro Fermentations of Beta-Glucan, Inulin and Xylooligosaccharide

Oligosaccharides Prepared By Acid Hydrolysis Of Polysaccharides From Pumpkin (Cucurbita Moschata) Pulp And Their Prebiotic Activities

In Vivo Prebiotic Properties of Alginate Oligosaccharides Prepared Through Enzymatic Hydrolysis of Alginate

Synthesis of Potential Prebiotic Α-Glucooligosaccharides Using Microbial Glucansucrase and Their in Vitro Fecal Fermentation.

Production, Structural Characterization, and In Vitro Assessment of the Prebiotic Potential of Butyl-Fructooligosaccharides

Evaluation Of Prebiotic Potential Of Three Marine Algae Oligosaccharides From Enzymatic Hydrolysis

In vitro fermentation of chitooligosaccharides and their effects on human fecal microbial community structure and metabolites

Synthesis and Evaluation of Antioxidant and Potential Prebiotic Activities of Acetylated and Butyrylated Fructo-Oligosaccharides

Comparison of the In-Vitro Effect of Five Prebiotics with Different Structure on Gut Microbiome and Metabolome

Fermentation characteristics and prebiotic potential of enzymatically synthesized butyryl-fructooligosaccharides

Dynamic response of different types of gut microbiota to fructooligosaccharides and inulin

Comprehensive evaluation of the prebiotic properties of Dendrobium officinale polysaccharides, β-glucan, and inulin during in vitro fermentation via multi-omics analysis

In vitro digestion and human gut microbiota fermentation of Bletilla striata polysaccharides and oligosaccharides

Non-digestible Galactomannan Oligosaccharides from Cassia Seed Gum Modulate Microbiota Composition and Metabolites of Human Fecal Inoculum